AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
596
Frequently Asked Questions
What is Market Cap of AbCellera Biologics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. AbCellera Biologics Inc market cap is $1.24B.
What is the 52-week high for AbCellera Biologics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. AbCellera Biologics Inc 52 week high is $5.82 as of September 05, 2025.
What is the 52-week low for AbCellera Biologics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. AbCellera Biologics Inc 52 week low is $1.89 as of September 05, 2025.
What is AbCellera Biologics Inc stock price today?
AbCellera Biologics Inc stock price today is $4.20.
What was AbCellera Biologics Inc stock price yesterday?
AbCellera Biologics Inc stock price yesterday was $4.16.
What is the PE ratio of AbCellera Biologics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. AbCellera Biologics Inc’s P/E ratio is -7.45.
What is the Price-to-Book ratio of AbCellera Biologics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. AbCellera Biologics Inc P/B ratio is 1.2337.
What is the 50-day moving average of AbCellera Biologics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. AbCellera Biologics Inc 50-day moving average is $4.28.
How many employess does AbCellera Biologics Inc has?
ABCL AbCellera Biologics Inc